|1.||Anes, Elsa: 1 article (12/2015)|
|2.||Constantino, Luís: 1 article (12/2015)|
|3.||Carmo, Nuno: 1 article (12/2015)|
|4.||Testa, Bernard: 1 article (12/2015)|
|5.||Simões, Marta Filipa: 1 article (12/2015)|
|6.||Valente, Emília: 1 article (12/2015)|
|7.||Pires, David: 1 article (12/2015)|
|8.||Mitchison, D A: 1 article (10/2015)|
|9.||Zhang, Y: 1 article (10/2015)|
|10.||Mortensen, N: 1 article (10/2015)|
|1.||Renal Insufficiency (Renal Failure)
12/01/2014 - "tuberculosis laboratory strain that was auxotrophic for pantothenate was found to be insensitive to PZA and to the active form, pyrazinoic acid (POA). "
06/01/1995 - "tuberculosis isolates are lower than those of pyrazinoic acid. "
04/01/1952 - "Pyrazinoic acid amide; an agent active against experimental murine tuberculosis."
12/01/2015 - "PZA is a first-line agent for the treatment of human tuberculosis and requires activation by a mycobacterial pyrazinamidase to form the active metabolite pyrazinoic acid (POA). "
10/05/2015 - "Correction for Spray Dried Aerosol Particles of Pyrazinoic Acid Salts for Tuberculosis Therapy."
|5.||Arthralgia (Joint Pain)
|3.||Uric Acid (Urate)
|1.||Drug Therapy (Chemotherapy)